Absci's CEO on what lured the biotech to the Big Apple

Absci Corp.’s announcement last week that it had opened a New York office had been in the works for a few months, founder and CEO Sean McClain said in a Tuesday interview. Why New York, where the Vancouver-based synthetic biology company has leased space in Carnegie Hall Tower? “We’re very excited to be on both coasts,” said McClain, who was attending an investor conference in Boston.